Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Revolution Medicines, Inc. (RVMD) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Revolution Medicines, Inc. (RVMD), most recent 12 months reported: revenue $0, net loss $1.77B, free cash flow -$1.23B. Latest balance sheet on file: liquid cash $3.94B, total debt $487.43M, net cash $3.45B. From SEC filings. More on Revolution Medicines, Inc.: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): PASSAGE BIO, INC. · Vaxcyte, Inc. · PHARMACYTE BIOTECH, INC. · REPLIMUNE GROUP, INC. · SAB BIOTHERAPEUTICS, INC. · Sana Biotechnology, Inc. · Solid Biosciences Inc. · SILEXION THERAPEUTICS CORP

Stock screener

Watchlist